| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.93B | 125.91B | 115.73B | 106.13B | 94.45B | 90.49B |
| Gross Profit | 28.90B | 27.94B | 24.42B | 20.65B | 19.07B | 18.01B |
| EBITDA | 16.46B | 15.62B | 13.60B | 12.44B | 11.80B | 11.39B |
| Net Income | 11.29B | 10.63B | 7.29B | 8.00B | 7.85B | 7.59B |
Balance Sheet | ||||||
| Total Assets | 74.77B | 81.35B | 85.77B | 81.11B | 79.43B | 75.64B |
| Cash, Cash Equivalents and Short-Term Investments | 26.89B | 30.52B | 39.40B | 44.33B | 47.32B | 44.31B |
| Total Debt | 504.00M | 199.00M | 600.00M | 197.00M | 233.36M | 213.15M |
| Total Liabilities | 17.77B | 22.00B | 22.36B | 18.73B | 17.29B | 16.23B |
| Stockholders Equity | 55.74B | 58.06B | 62.27B | 61.42B | 62.02B | 59.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.14B | 10.15B | 7.36B | 7.53B | 9.32B |
| Operating Cash Flow | 0.00 | 9.67B | 10.43B | 7.66B | 7.67B | 9.47B |
| Investing Cash Flow | 0.00 | -2.81B | -8.54B | -949.00M | -217.88M | -793.86M |
| Financing Cash Flow | 0.00 | -16.09B | -7.82B | -9.10B | -5.03B | -3.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥85.26B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
76 Outperform | ¥151.12B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥147.08B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
74 Outperform | ¥267.56B | 28.54 | ― | 0.22% | 25.00% | 62.07% | |
66 Neutral | ¥166.42B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥30.85B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |